Araştırma Makalesi
BibTex RIS Kaynak Göster

Deneysel Diyabetik Ratlarda Ardıç (Juniperus communis L.) Yağının Nefropati Üzerine Etkileri

Yıl 2018, Cilt: 7 Sayı: 2, 192 - 199, 27.12.2018
https://doi.org/10.31196/huvfd.508981

Öz

Hiperglisemi
aracılı oksidatif stres diyabetik nefropatinin (DN) patogenezinde önemli bir
rol oynar. Bu çalışmada, streptozotosin (STZ) ile indüklenmiş diyabetik
ratlarda ardıç (Juniper berry; JB) yağının renoprotektif etkisinin
araştırılması amaçlandı. Bu amaçla, 40 adet erkek Wistar albino rat rastgele seçilerek;
kontrol, diyabetes mellitus (DM), DM+akarboz, DM+ardıç yağı ve ardıç yağı olmak
üzere beş gruba ayrıldı. Deneysel diyabet, tek dozluk (55 mg/kg, periton içi
[i.p]) STZ enjeksiyonu ile oluşturuldu. DM+ardıç ve ardıç grubu ratların
yemlerine 50 ml/kg JB yağı katılarak verildi. 28 günlük deneme süresi sonunda
ratlar sakrifiye edilerek kan ve doku örnekleri alındı. Böbrek dokusunda
histopatolojik değişiklikler, immunohistokimyasal olarak caspase-3 (Kaspaz-3) ekspresyonu,
biyokimyasal olarak malondialdehit
(MDA)
  ve glutasyon (GSH) konsantrasyonları ve
katalaz aktiviteleri çalışıldı. Serumda ise üre ve kreatinin düzeyleri incelendi. DM grubu
ratlarda, histopatolojik olarak tubulus epitel hücrelerinde dejenerasyon ve
nekroz, glomerular yapıda bozulma gözlemlenirken, immunohistokimyasal olarak
tubul epitel hücrelerinde caspase-3 immun reaktivitesi yüksek saptandı.
Biyokimyasal olarak DM grubu ratların böbrek dokusunda, MDA konsantrasyonu
kontrol grubuna göre anlamlı olarak yüksek ve GSH konsantrasyonu ve katalaz
aktivitesi anlamlı olarak düşük bulundu. Ayrıca DM grubunda serum üre ve kreatinin konsantrasyonları
kontrol grubundan anlamlı olarak yüksek bulundu. DM+ardıç grubu ratlarda ise,
ardıç tedavisi sonucu histopatolojik değişikliklerin düzeldiği, caspase-3 immun
reaktivitesinin azaldığı ve biyokimyasal parametrelerin iyileştiği tespit
edildi. Sonuç olarak, ardıç yağının denysel diyabetik ratlarda böbreği koruyucu
etkileri olduğu belirlendi.

Kaynakça

  • Allen DA, Harwood SM, Varagunam M, Raftery MJ, Yaqoob MM, 2003: High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J, 17(8), 908-910.
  • Benson L, 1962: Plant taxonomy, methods and principles. Ronald Press. New York, NY.
  • Beutler E, Duron O, Kelly BM, 1963: Improved method for the determination of blood glutathione. J Lab Clin Med, 61, 882-890.
  • Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C, 2005: Mechanisms of antioxidant and prooxidant effects of a-lipoic acid in the diabetic and non-diabetic kidney. Kidney Int, 67(4), 1371–1380.
  • Brezniceanu ML, Liu F, Wei CC, Chénier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK, 1997: Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J Am Soc Nephrol, 8, 1405-1414.
  • Dalla VM, Saller A, Mauer M, Fioretto P, 2001: Role of mesangial expansion in the pathogenesis of diabetic nephropathy. J Nephrol, 14(4), 51–57.
  • Das J, Sil PC, 2012: Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino acids, 43(4), 1509-1523.
  • de Haan JB, Stefanovic N, Nikolic-Paterson D, Scurr LL, Croft KD, Mori TA, Hertzog P, Kola I, Atkins RC, Tesch GH, 2005: Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol, 289, 544-551.
  • Dormandy TL, 1980: Free radical reactions in biological systems. Ann R Coll Surg Engl, 62, 188-194.
  • Dunlop M, 2000: Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int, 77, 3-S12.
  • Filipowicz N, Kamiński M, Kurlenda J, Asztemborska M, Ochocka JR, 2003: Antibacterial and antifungal activity of juniper berry oil and its selected components. Phytother Res, 17(3), 227-231.
  • Fioretto P, Stehouwer CD, Mauer M, Chiesura-Corona M, Brocco E, Carraro A, Bortoloso E, van Hinsbergh VW, Crepaldi G, Nosadini R, 1998: Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia, 41(2), 233–236.
  • Forbes JM, Coughlan MT, Cooper ME, 2008: Oxidative stress as amajor culprit in kidney disease in diabetes. Diabetes, 57, 1446–1454.
  • Freeman BA, Crapo JD,0 1981: Hyperoxia increases oxygen radical production in rat lung and lung mitochondria. J Biol Chem, 256, 10986-10992.
  • Ha H, Lee HB, 2000: Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int, 58(Suppl. 77), 19-25.
  • Harris DC, 2001: Tubulointerstitial renal disease. Curr Opin Nephrol Hypertens, 10, 303–313.
  • Huang THW, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y, 2005: Anti-diabetic action of Punica granatum flower extract: activation of PPAR-c and identification of an active component. Toxicol Appl Pharmacol, 207, 160–169.
  • Kelly DJ, Stein-Oakley A, Zhang Y, Wassef L, Maguire J, Koji T, Thomson N, Wilkinson-Berka JL, Gilbert RE, 2004: Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade. Nephrology (Carlton), 9, 7-13.
  • Kikkawa R, Koya D, Haneda M, 2003: Progression of diabetic nephropathy. Am. J. Kidney Dis, 41(3), 19–21.
  • Kumar D, Robertson S, Burns KD, 2004: Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem, 259, 67-70.
  • Lalenti S, Moncada M, Rosa D, 1993: Modulation of adjuvant arthritis by endogenous nitric oxide. Brit J Pharmacol, 110, 701- 706.
  • Larkins RG, Dunlop ME, 1992: The link between hyperglycaemia and diabetic nephropathy. Diabetologia, 35, 499–504.
  • Lartillot S, Kedziora P, Athias A, 1988: Purification and characterization of a new fungal catalase. Prep Biochem, 18(3), 241-246.
  • Ledwozyw A, Michalak J, Stepień A, Kadziołka A, 1986: The relationship between plasma triglycerides, cholesterol, total lipids andl ipid peroxidation products during human atherosclerosis. Clin Chim Acta, 155(3), 275- 83.
  • Lee YM, Kim H, Hong EK, Kang BH, Kim SJ 2000: Water extract of 1:1 mixture of Phellodendron cortex and Aralia cortex has inhibitory effects on oxidative stress in kidney of diabetic rats. J Ethnopharmacol, 73, 429–36.
  • Lewis JB, 1999: Diabetic nephropathy in patients with type II diabetes. Geriatr Nephrol Urol, 9(3), 167–175.
  • Li J, Qu X, Bertram JF, 2009: Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol, 175(4), 1380-1388.
  • Liu G, Sun Y, Li Z, Song T, Wang H, Zhang Y, Ge Z, 2008: Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem Biophys Res Commun, 370(4), 651-656.
  • Madhuri K, Naik PR, 2017: Modulatory effect of garcinol in streptozotocin-induced diabetic Wistar rats. Arch Physiol Biochem, 123(5), 322-329.
  • Manna P, Sinha M, Sil PC, 2008: Amelioration of cadmium-induced cardiac impairment by taurine. Chem Biol Interact, 174, 88-97.
  • Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J, 2012: The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J, 12(1), 5.
  • Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC, 1984: Structural-functional relationships in diabetic nephropathy. J Clin Invest, 74, 1143-1155.
  • Motshakeri M, Ebrahimi M, Goh YM, Othman HH, Hair-Bejo M, Mohamed S, 2014: Effects of brown seaweed (Sargassum polycystum) extracts on kidney, liver, and pancreas of type 2 diabetic rat model. J Evid Based Complementary Altern Med. Article ID 379407.
  • Nicolle E, Souard F, Faure P, Boumendjel A, 2011: Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure activity relationship. Curr Med Chem, 18(17), 2661-2672.
  • Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J, 2003: Early oxidative stress in diabetic kidney: effect of DL-a-lipoic acid. Free Radic Biol Med, 34, 186-95.
  • Ochacka Jr, Asztemborska M, Zook, Dr, Sybılska D, Perez G, Ossıcını L, 1996: Enantiomers of monoterpenic hydrocarbons in essential oil from Juniperus communis. Phytochemistry, 44, 869-873.
  • Palsamy P, Subramanian S, 2011: Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta, 1812, 719-731.
  • Rajarajeswari N, Pari L, 2011: Antioxidant role of coumarin on streptozotocin-nicotinamide-induced type 2 diabetic rats. J Biochem Mol Toxicol, 25, 355-361.
  • Reutens AT, 2013: Epidemiology of diabetic kidney disease. Med Clin North Am, 97, 1-18.
  • Rossing P, Rossing K, Jacobsen P, Parving HH, 1995: Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes, 44(7), 739–743
  • Sakulnarmrat K, Konczak I, 2012: Composition of native Australian herbs polyphenolic-rich fractions and in vitro inhibitory activities against key enzymes relevant to metabolic syndrome. Food Chem, 134(2), 1011-1019.
  • Sellamuthu PS, Arulselvan P, Muniappan BP, Fakurazi S, Kandasamy M, 2013: Mangiferin from Salacia chinensis prevents oxidative stress and protects pancreatic β-cells in streptozotocin-induced diabetic rats. J Med Food, 16(8), 719-727.
  • Shahidi F, Wanasundara PK, Wanasundara PD, 1992: Phenolic antioxidants. Crit Rev Food Sci Nutr, 32, 67-103.
  • Sheela N, Jose MA, Sathyamurthy D, Kumar BN, 2013: Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. Iran J Kidney Dis, 7, 117-123.
  • Subash-Babu P, Alshatwi AA, Ignacimuthu S, 2014: Beneficial antioxidative and antiperoxidative effect of cinnamaldehyde protect streptozotocin-induced pancreatic beta-cells damage in wistar rats. Biomol Ther (Seoul), 22(1), 47-54.
  • Tan AL, Forbes JM, Cooper ME, 2007: AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol, 27(2), 130-143.
  • Uyar A, Yaman T, Keles OF, Alkan EE, Celik I, Yener Z, 2017: Protective effects of Bryonia multiflora extract on pancreatic beta cells, liver and kidney of streptozotocin-induced diabetic rats: histopathological and immunohistochemical investigations. Indian J Pharm Educ Res, 51(3), Suppl:S403-11.
  • Wagener FADTG, Dekker D, Berden JH, Scharstuhl A, Van der Vlag J, 2009: The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis, 14(12), 1451-1458.
  • Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J, 2009: Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie, 91, 261-270.
  • Yaman T, Uyar A, Celik I, Alkan EE, Keles OF, Yener Z, 2017: Histopathological and immunohistochemical study of antidiabetic effects of Heracleum persicum extract in experimentally diabetic rats. IJPER, 51(3), 450-457.
  • Yaman T, Yener Z, Celik I, 2016: Histopathological and biochemical investigations of protective role of honey in rats with experimental aflatoxicosis. BMC Complement Altern Med, 16(1), 232.
  • Yeşilbağ D, Cengiz SS, Cetin I, Meral Y, Biricik H, 2014: Influence of juniper (Juniperus communis) oil on growth performance and meat quality as a natural antioxidant in quail diets. Br Poult Sci, 55(4), 495-500.

Effects of Juniperus communis L. Oil on Nephropathy in Experimental Diabetic Rats

Yıl 2018, Cilt: 7 Sayı: 2, 192 - 199, 27.12.2018
https://doi.org/10.31196/huvfd.508981

Öz

Hyperglycaemia-mediated oxidative stress plays an
important role in the pathogenesis of diabetic nephropathy. The present study
investigated the renoprotective effect of Juniper (Juniper berry; JB) oil in
rats with streptozotocin (STZ)-induced diabetes.
For this, 40
male Wistar albino rats were divided into five group, namely, control, diabetes
mellitus (DM), DM+acarbose, DM + JB oil and JB oil groups. Experimental
diabetes was established by injecting the rats with a single dose (55 mg/kg) of
STZ intraperitoneally. The rats in the DM+ardıç oil and ardıç oil groups
received 50 ml JB oil/kg diet. After 28 days, the rats were sacrificed and
their blood and tissue samples were obtained. Histopathological changes,
caspase-3 immunoexpression, malondialdehyde MDA and glutathione (
GSH) concentration and catalase activities in the
kidney tissues of the rats were examined. Moreover, serum urea and creatinine
levels were examined. Histopathologically, the rats in the DM group showed
degeneration and necrosis of tubular epithelial cells and destruction of
glomerular structures. Immunohistochemically, these rats showed increased
caspase-3 immunoreactivity in the tubular epithelial cells. Biochemically, MDA
concentration was significantly higher in the kidney tissue of the rats in the
DM group than that of the rats in the control group. GSH concentration and
catalase activities were significantly lower in the kidney tissue of the rats
in the DM group than that of the rats in the control group. Moreover, serum
urea and creatinine levels were significantly higher in the rats in the DM
group than those in the control group. The rats in the DM + JB oil group showed
an improvement in STZ-induced histopathological changes. Moreover, these rats
showed decreased caspase-3 immunoexpression in the kidney tissue and improved
biochemical parameters. Thus, these results indicate that JB oil exerts
protective effects in the kidneys of diabetic rats.

Kaynakça

  • Allen DA, Harwood SM, Varagunam M, Raftery MJ, Yaqoob MM, 2003: High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J, 17(8), 908-910.
  • Benson L, 1962: Plant taxonomy, methods and principles. Ronald Press. New York, NY.
  • Beutler E, Duron O, Kelly BM, 1963: Improved method for the determination of blood glutathione. J Lab Clin Med, 61, 882-890.
  • Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C, 2005: Mechanisms of antioxidant and prooxidant effects of a-lipoic acid in the diabetic and non-diabetic kidney. Kidney Int, 67(4), 1371–1380.
  • Brezniceanu ML, Liu F, Wei CC, Chénier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK, 1997: Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J Am Soc Nephrol, 8, 1405-1414.
  • Dalla VM, Saller A, Mauer M, Fioretto P, 2001: Role of mesangial expansion in the pathogenesis of diabetic nephropathy. J Nephrol, 14(4), 51–57.
  • Das J, Sil PC, 2012: Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino acids, 43(4), 1509-1523.
  • de Haan JB, Stefanovic N, Nikolic-Paterson D, Scurr LL, Croft KD, Mori TA, Hertzog P, Kola I, Atkins RC, Tesch GH, 2005: Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol, 289, 544-551.
  • Dormandy TL, 1980: Free radical reactions in biological systems. Ann R Coll Surg Engl, 62, 188-194.
  • Dunlop M, 2000: Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int, 77, 3-S12.
  • Filipowicz N, Kamiński M, Kurlenda J, Asztemborska M, Ochocka JR, 2003: Antibacterial and antifungal activity of juniper berry oil and its selected components. Phytother Res, 17(3), 227-231.
  • Fioretto P, Stehouwer CD, Mauer M, Chiesura-Corona M, Brocco E, Carraro A, Bortoloso E, van Hinsbergh VW, Crepaldi G, Nosadini R, 1998: Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia, 41(2), 233–236.
  • Forbes JM, Coughlan MT, Cooper ME, 2008: Oxidative stress as amajor culprit in kidney disease in diabetes. Diabetes, 57, 1446–1454.
  • Freeman BA, Crapo JD,0 1981: Hyperoxia increases oxygen radical production in rat lung and lung mitochondria. J Biol Chem, 256, 10986-10992.
  • Ha H, Lee HB, 2000: Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int, 58(Suppl. 77), 19-25.
  • Harris DC, 2001: Tubulointerstitial renal disease. Curr Opin Nephrol Hypertens, 10, 303–313.
  • Huang THW, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y, 2005: Anti-diabetic action of Punica granatum flower extract: activation of PPAR-c and identification of an active component. Toxicol Appl Pharmacol, 207, 160–169.
  • Kelly DJ, Stein-Oakley A, Zhang Y, Wassef L, Maguire J, Koji T, Thomson N, Wilkinson-Berka JL, Gilbert RE, 2004: Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade. Nephrology (Carlton), 9, 7-13.
  • Kikkawa R, Koya D, Haneda M, 2003: Progression of diabetic nephropathy. Am. J. Kidney Dis, 41(3), 19–21.
  • Kumar D, Robertson S, Burns KD, 2004: Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem, 259, 67-70.
  • Lalenti S, Moncada M, Rosa D, 1993: Modulation of adjuvant arthritis by endogenous nitric oxide. Brit J Pharmacol, 110, 701- 706.
  • Larkins RG, Dunlop ME, 1992: The link between hyperglycaemia and diabetic nephropathy. Diabetologia, 35, 499–504.
  • Lartillot S, Kedziora P, Athias A, 1988: Purification and characterization of a new fungal catalase. Prep Biochem, 18(3), 241-246.
  • Ledwozyw A, Michalak J, Stepień A, Kadziołka A, 1986: The relationship between plasma triglycerides, cholesterol, total lipids andl ipid peroxidation products during human atherosclerosis. Clin Chim Acta, 155(3), 275- 83.
  • Lee YM, Kim H, Hong EK, Kang BH, Kim SJ 2000: Water extract of 1:1 mixture of Phellodendron cortex and Aralia cortex has inhibitory effects on oxidative stress in kidney of diabetic rats. J Ethnopharmacol, 73, 429–36.
  • Lewis JB, 1999: Diabetic nephropathy in patients with type II diabetes. Geriatr Nephrol Urol, 9(3), 167–175.
  • Li J, Qu X, Bertram JF, 2009: Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol, 175(4), 1380-1388.
  • Liu G, Sun Y, Li Z, Song T, Wang H, Zhang Y, Ge Z, 2008: Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem Biophys Res Commun, 370(4), 651-656.
  • Madhuri K, Naik PR, 2017: Modulatory effect of garcinol in streptozotocin-induced diabetic Wistar rats. Arch Physiol Biochem, 123(5), 322-329.
  • Manna P, Sinha M, Sil PC, 2008: Amelioration of cadmium-induced cardiac impairment by taurine. Chem Biol Interact, 174, 88-97.
  • Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J, 2012: The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J, 12(1), 5.
  • Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC, 1984: Structural-functional relationships in diabetic nephropathy. J Clin Invest, 74, 1143-1155.
  • Motshakeri M, Ebrahimi M, Goh YM, Othman HH, Hair-Bejo M, Mohamed S, 2014: Effects of brown seaweed (Sargassum polycystum) extracts on kidney, liver, and pancreas of type 2 diabetic rat model. J Evid Based Complementary Altern Med. Article ID 379407.
  • Nicolle E, Souard F, Faure P, Boumendjel A, 2011: Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure activity relationship. Curr Med Chem, 18(17), 2661-2672.
  • Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J, 2003: Early oxidative stress in diabetic kidney: effect of DL-a-lipoic acid. Free Radic Biol Med, 34, 186-95.
  • Ochacka Jr, Asztemborska M, Zook, Dr, Sybılska D, Perez G, Ossıcını L, 1996: Enantiomers of monoterpenic hydrocarbons in essential oil from Juniperus communis. Phytochemistry, 44, 869-873.
  • Palsamy P, Subramanian S, 2011: Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta, 1812, 719-731.
  • Rajarajeswari N, Pari L, 2011: Antioxidant role of coumarin on streptozotocin-nicotinamide-induced type 2 diabetic rats. J Biochem Mol Toxicol, 25, 355-361.
  • Reutens AT, 2013: Epidemiology of diabetic kidney disease. Med Clin North Am, 97, 1-18.
  • Rossing P, Rossing K, Jacobsen P, Parving HH, 1995: Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes, 44(7), 739–743
  • Sakulnarmrat K, Konczak I, 2012: Composition of native Australian herbs polyphenolic-rich fractions and in vitro inhibitory activities against key enzymes relevant to metabolic syndrome. Food Chem, 134(2), 1011-1019.
  • Sellamuthu PS, Arulselvan P, Muniappan BP, Fakurazi S, Kandasamy M, 2013: Mangiferin from Salacia chinensis prevents oxidative stress and protects pancreatic β-cells in streptozotocin-induced diabetic rats. J Med Food, 16(8), 719-727.
  • Shahidi F, Wanasundara PK, Wanasundara PD, 1992: Phenolic antioxidants. Crit Rev Food Sci Nutr, 32, 67-103.
  • Sheela N, Jose MA, Sathyamurthy D, Kumar BN, 2013: Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. Iran J Kidney Dis, 7, 117-123.
  • Subash-Babu P, Alshatwi AA, Ignacimuthu S, 2014: Beneficial antioxidative and antiperoxidative effect of cinnamaldehyde protect streptozotocin-induced pancreatic beta-cells damage in wistar rats. Biomol Ther (Seoul), 22(1), 47-54.
  • Tan AL, Forbes JM, Cooper ME, 2007: AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol, 27(2), 130-143.
  • Uyar A, Yaman T, Keles OF, Alkan EE, Celik I, Yener Z, 2017: Protective effects of Bryonia multiflora extract on pancreatic beta cells, liver and kidney of streptozotocin-induced diabetic rats: histopathological and immunohistochemical investigations. Indian J Pharm Educ Res, 51(3), Suppl:S403-11.
  • Wagener FADTG, Dekker D, Berden JH, Scharstuhl A, Van der Vlag J, 2009: The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis, 14(12), 1451-1458.
  • Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J, 2009: Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie, 91, 261-270.
  • Yaman T, Uyar A, Celik I, Alkan EE, Keles OF, Yener Z, 2017: Histopathological and immunohistochemical study of antidiabetic effects of Heracleum persicum extract in experimentally diabetic rats. IJPER, 51(3), 450-457.
  • Yaman T, Yener Z, Celik I, 2016: Histopathological and biochemical investigations of protective role of honey in rats with experimental aflatoxicosis. BMC Complement Altern Med, 16(1), 232.
  • Yeşilbağ D, Cengiz SS, Cetin I, Meral Y, Biricik H, 2014: Influence of juniper (Juniperus communis) oil on growth performance and meat quality as a natural antioxidant in quail diets. Br Poult Sci, 55(4), 495-500.
Toplam 52 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Araştıma
Yazarlar

Turan Yaman Bu kişi benim

Ahmet Ufuk Kömüroğlu Bu kişi benim

Yayımlanma Tarihi 27 Aralık 2018
Gönderilme Tarihi 21 Mayıs 2018
Kabul Tarihi 25 Kasım 2018
Yayımlandığı Sayı Yıl 2018 Cilt: 7 Sayı: 2

Kaynak Göster

APA Yaman, T., & Kömüroğlu, A. U. (2018). Deneysel Diyabetik Ratlarda Ardıç (Juniperus communis L.) Yağının Nefropati Üzerine Etkileri. Harran Üniversitesi Veteriner Fakültesi Dergisi, 7(2), 192-199. https://doi.org/10.31196/huvfd.508981
AMA Yaman T, Kömüroğlu AU. Deneysel Diyabetik Ratlarda Ardıç (Juniperus communis L.) Yağının Nefropati Üzerine Etkileri. Harran Univ Vet Fak Derg. Aralık 2018;7(2):192-199. doi:10.31196/huvfd.508981
Chicago Yaman, Turan, ve Ahmet Ufuk Kömüroğlu. “Deneysel Diyabetik Ratlarda Ardıç (Juniperus Communis L.) Yağının Nefropati Üzerine Etkileri”. Harran Üniversitesi Veteriner Fakültesi Dergisi 7, sy. 2 (Aralık 2018): 192-99. https://doi.org/10.31196/huvfd.508981.
EndNote Yaman T, Kömüroğlu AU (01 Aralık 2018) Deneysel Diyabetik Ratlarda Ardıç (Juniperus communis L.) Yağının Nefropati Üzerine Etkileri. Harran Üniversitesi Veteriner Fakültesi Dergisi 7 2 192–199.
IEEE T. Yaman ve A. U. Kömüroğlu, “Deneysel Diyabetik Ratlarda Ardıç (Juniperus communis L.) Yağının Nefropati Üzerine Etkileri”, Harran Univ Vet Fak Derg, c. 7, sy. 2, ss. 192–199, 2018, doi: 10.31196/huvfd.508981.
ISNAD Yaman, Turan - Kömüroğlu, Ahmet Ufuk. “Deneysel Diyabetik Ratlarda Ardıç (Juniperus Communis L.) Yağının Nefropati Üzerine Etkileri”. Harran Üniversitesi Veteriner Fakültesi Dergisi 7/2 (Aralık 2018), 192-199. https://doi.org/10.31196/huvfd.508981.
JAMA Yaman T, Kömüroğlu AU. Deneysel Diyabetik Ratlarda Ardıç (Juniperus communis L.) Yağının Nefropati Üzerine Etkileri. Harran Univ Vet Fak Derg. 2018;7:192–199.
MLA Yaman, Turan ve Ahmet Ufuk Kömüroğlu. “Deneysel Diyabetik Ratlarda Ardıç (Juniperus Communis L.) Yağının Nefropati Üzerine Etkileri”. Harran Üniversitesi Veteriner Fakültesi Dergisi, c. 7, sy. 2, 2018, ss. 192-9, doi:10.31196/huvfd.508981.
Vancouver Yaman T, Kömüroğlu AU. Deneysel Diyabetik Ratlarda Ardıç (Juniperus communis L.) Yağının Nefropati Üzerine Etkileri. Harran Univ Vet Fak Derg. 2018;7(2):192-9.